Quest voluntarily recalls some of its MPS delivery sets for use during open heart surgery

Tim Casey | | Cardiovascular Business | Interventional Cardiology

Quest Medical voluntarily recalled certain lots of its Myocardial Protection System (MPS) delivery sets on Oct. 28 after finding the products had a possible seal failure that could lead to blood loss in patients.

The company said in a news release that it had received 20 complaints alleging the seal failure, which resulted in 16 patients losing blood during surgeries. No patients have been injured due to the alleged issue, according to Quest.

The recalled products were manufactured from May 2015 to September 2015 and distributed from June 2015 to September 2015.

The recall affects some lots of the MPS delivery set with arrest agent and additive cassettes, heat exchanger and 10-foot delivery tubing; the MPS delivery set with 6-foot delivery tubing; and the MPS low volume delivery set.

The MPS delivery set is intended for perfusionists and physicians to deliver whole blood and/or cardio-protective drugs and solutions to the heart during open heart surgery.

Tim Casey,

Executive Editor

Tim Casey joined TriMed Media Group in 2015 as Executive Editor. For the previous four years, he worked as an editor and writer for HMP Communications, primarily focused on covering managed care issues and reporting from medical and health care conferences. He was also a staff reporter at the Sacramento Bee for more than four years covering professional, college and high school sports. He earned his undergraduate degree in psychology from the University of Notre Dame and his MBA degree from Georgetown University.

Related Content

Cardiologists reflect on developing primary PCI in face of criticism and pushback
How TAVR valve choice impacts outcomes when treating type 1 bicuspid AS
IVUS-guided PCI reduces risks in patients with diabetes
Medtronic using AI to identify more TAVR patients in need
SAVR linked to higher 10-year survival rate than TAVR for low-risk patients
LAAC with Watchman FLX reduces bleeding risks after AFib ablation

Around the web

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business
What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."